Cargando…

Dupilumab-induced phenotype switching from atopic dermatitis to psoriasis

Detalles Bibliográficos
Autores principales:	Varma, Aakaash, Levitt, Jacob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Notes & Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033615/ https://www.ncbi.nlm.nih.gov/pubmed/32095497 http://dx.doi.org/10.1016/j.jdcr.2020.01.012

Ejemplares similares

The utility of dupilumab for use in the pediatric population
por: Varma, Aakaash, et al.
Publicado: (2019)

Alopecia areata after dupilumab for atopic dermatitis
por: Mitchell, Krystal, et al.
Publicado: (2018)

Dupilumab for atopic dermatitis
Publicado: (2019)

Alopecia areata-like and psoriasis after dupilumab use for atopic dermatitis()()
por: Maiolini, Viviane Maria, et al.
Publicado: (2021)

Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
por: Gelato, Federica, et al.
Publicado: (2023)

Psoriasis appearing after dupilumab therapy in atopic dermatitis: A case report
por: Kim, Ho Seung, et al.
Publicado: (2020)

Pustular Psoriasis in a Patient Treated with Dupilumab for Atopic Dermatitis: A Case Report
por: Liu, Li, et al.
Publicado: (2023)

Did dupilumab unmask smoldering mycosis fungoides?
por: Toker, Michelle, et al.
Publicado: (2023)

Conjunctivitis in patients with atopic dermatitis treated with dupilumab
por: Ferreira, Sandra, et al.
Publicado: (2020)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
por: Zubek, Amanda E., et al.
Publicado: (2020)

Practical Management of Patients with Atopic Dermatitis on Dupilumab
por: Papp, Kim A., et al.
Publicado: (2021)

Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective
por: de Bruin-Weller, Marjolein, et al.
Publicado: (2021)

The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis
por: Kamal, Mohamed A., et al.
Publicado: (2021)

Improvement of atopic dermatitis and alopecia universalis with dupilumab
por: Alotaibi, Lama, et al.
Publicado: (2021)

Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
por: Shan, Jinpeng, et al.
Publicado: (2022)

Full scalp hair regrowth in a 4-year-old girl with alopecia areata and atopic dermatitis treated with dupilumab
por: Gruenstein, Diana, et al.
Publicado: (2020)

Biologics-Induced Immunophenotypic Cross-Switching in Patients with Psoriasis and Atopic Dermatitis
por: Li, Yanyan, et al.
Publicado: (2023)

Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis
por: Maudinet, Adrien, et al.
Publicado: (2019)

The evaluation of dupilumab treatment response in atopic dermatitis patients
por: Askin, Ozge, et al.
Publicado: (2020)

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
por: Cho, Sung Kyung, et al.
Publicado: (2021)

Psoriasis and Atopic Dermatitis
por: Griffiths, Christopher E. M., et al.
Publicado: (2017)

Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients
por: Tavecchio, Simona, et al.
Publicado: (2020)

Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis
por: WOLLENBERG, Andreas, et al.
Publicado: (2022)

Letter in response to the case report: “Recalcitrant generalized granuloma annulare treated successfully with dupilumab”
por: Paganini, Claudia, et al.
Publicado: (2023)

Treatment of chronic bullous disease of childhood with dupilumab after dapsone-induced methemoglobinemia in a 2-year-old female patient
por: Yousefian, Faraz, et al.
Publicado: (2023)

Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis
por: Call, John E., et al.
Publicado: (2020)

Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma
por: Bansal, Ashish, et al.
Publicado: (2021)

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
por: Peterson, Danielle M., et al.
Publicado: (2021)

Efficacy and safety of dupilumab in two adolescents with severe atopic dermatitis
por: Giavina-Bianchi, Mara, et al.
Publicado: (2021)

Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab
por: MIYAMOTO, Shoko, et al.
Publicado: (2022)

Pharmacokinetics, pharmacodynamics, and exposure–efficacy of dupilumab in adults with atopic dermatitis
por: Kamal, Mohamed A., et al.
Publicado: (2022)

Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
por: Esposito, Maria, et al.
Publicado: (2022)

Dupilumab: Direct Cost and Clinical Evaluation in Patients with Atopic Dermatitis
por: Ferrari, Marco, et al.
Publicado: (2023)

The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis
por: Spekhorst, Lotte S., et al.
Publicado: (2023)

Effectiveness of dupilumab for chronic prurigo in elderly patients with atopic dermatitis()
por: Mitsuyama, Shinji, et al.
Publicado: (2023)

Treatment of Severe Atopic Dermatitis with Dupilumab in Patients with Advanced Cancer
por: Tanczosova, Milena, et al.
Publicado: (2023)

Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
por: Dubini, Marco, et al.
Publicado: (2023)

Alcohol-induced facial flushing in a patient with atopic dermatitis treated with dupilumab
por: Igelman, Sean J., et al.
Publicado: (2020)

Overlapping Features of Psoriasis and Atopic Dermatitis: From Genetics to Immunopathogenesis to Phenotypes
por: Tsai, Ya-Chu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kg2d7agr7v8ev742r2rq488v2u